Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE: 688091)
Health Care · Pharmaceuticals · CN
CN¥41.18
+0.78% today · -49.6% 1Y
Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE: 688091) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.25B and employs 437 people.
Over the last twelve months the share price has lost 49.6%, trading between 35.28 and 83.60.
Tweenvest scores Shanghai Yizhong Pharmaceutical Co., Ltd. across four factors: quality 66/100, value 39/100. Its strongest factor is quality.
688091 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.25B
- Revenue (TTM)
- $47.00M
- P/E
- 121.09
- EPS
- 0.34
- Dividend yield
- —
- Beta (5Y)
- -0.45
- 52-week high
- CN¥83.60
- 52-week low
- CN¥35.28
- Avg volume (3M)
- —
- Shares outstanding
- 204.80M
- Employees
- 437
- Next earnings
- —
About Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It also offers paclitaxel polymer nanomicelles for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, gynecological tumors, etc. The company was founded in 2009 and is headquartered in Shanghai, China.
- ISIN
- CNE1000050F4
- Founded
- 2009
- Listed since
- Sep 9, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.